Paper40600445
Multi-modal models using fMRI, urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease.
Shao X and 11 others. Diabetes Obes Metab, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Multi-modal models using fMRI, urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease. Papers, record 40600445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40600445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multi-modal models using fMRI, urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Diabetic Nephropathies | Major topic |
| Humans | |
| Male | |
| Female | |
| Prognosis | |
| Middle Aged | |
| Adult | |
| Aged | |
| Diffusion Tensor Imaging | |
| Machine Learning | |
| Risk Assessment |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21ZXGWSY00100 | Tianjin Science and Technology Major Special Project and Engineering Public Health Science and Technology Major Special Project | PubMed | ||
| TJSJMYXYC-D2-014 | The Second Batch of High-Level Talents Selection Project in Health Industry in Tianjin | PubMed | ||
| TJWJ2024QN032 | Science and Technology Project of Tianjin Health Commission | PubMed | ||
| 22JCZDJC00590 | Tianjin Natural Science Foundation Key Projects | PubMed | ||
| 2024B012 | President's Fund of Nanfang Hospital, Southern Medical University | PubMed | ||
| TJYXZDXK-032A | Tianjin Key Medical Discipline (Specialty) Construct Project | PubMed | ||
| ZXY-ZDSYSZD-1 | Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital | PubMed | ||
| First Level Leading Talent Project of 123 Climbing Plan for Clinical Talents of Tianjin Medical University | PubMed |
Source PubMed
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42453508 | Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42453508 | PubMed |
| 42279544 | Multimodal Magnetic Resonance Imaging in Diabetic Kidney Disease: From Pathophysiological Insights to Clinical Applications. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42279544 | PubMed |
| 41639881 | Risk stratification in diabetic kidney disease: a review of prediction models for methodological advances and clinical application. | J Transl Med | 2026 | https://conductscience.org/library/papers/41639881 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD300LF | 146722 | PubTator's text mining | https://conductscience.org/library/genes/146722 | NCBI Gene |
| CST4 | 1472 | PubTator's text mining | https://conductscience.org/library/genes/1472 | NCBI Gene |
| MMRN2 | 79812 | PubTator's text mining | https://conductscience.org/library/genes/79812 | NCBI Gene |
| SERPINA1 | 5265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40600445
GET https://conductscience.org/api/papers/v1/40600445/authors